Cargando…

Glucose Tolerance Test and Pharmacokinetic Study of Kaempferia parviflora Extract in Healthy Subjects

Kaempferia parviflora Wall. ex Baker (KP), Krachaidam in Thai or Thai ginseng, is a herbal medicine that has many potential pharmacological effects. The effect of KP extract on blood glucose level in rodent was reported. This study focused on the oral glucose tolerance test and pharmacokinetic study...

Descripción completa

Detalles Bibliográficos
Autores principales: Sripanidkulchai, Bungorn, Mekjaruskul, Catheleeya, Areemit, Rosawan, Cheawchanwattana, Areewan, Sithithaworn, Jiraporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566825/
https://www.ncbi.nlm.nih.gov/pubmed/31130666
http://dx.doi.org/10.3390/nu11051176
_version_ 1783426937908101120
author Sripanidkulchai, Bungorn
Mekjaruskul, Catheleeya
Areemit, Rosawan
Cheawchanwattana, Areewan
Sithithaworn, Jiraporn
author_facet Sripanidkulchai, Bungorn
Mekjaruskul, Catheleeya
Areemit, Rosawan
Cheawchanwattana, Areewan
Sithithaworn, Jiraporn
author_sort Sripanidkulchai, Bungorn
collection PubMed
description Kaempferia parviflora Wall. ex Baker (KP), Krachaidam in Thai or Thai ginseng, is a herbal medicine that has many potential pharmacological effects. The effect of KP extract on blood glucose level in rodent was reported. This study focused on the oral glucose tolerance test and pharmacokinetic study in healthy volunteers administered with KP extract (90 and 180 mg/day, placebo). The oral glucose tolerance tests were performed at baselines and 28-days of administration. The pharmacokinetics were determined after a single dose administration of the tested products using 3,5,7,3′,4′-pentamethoxyflavone (PMF) and 5,7,4′-trimethoxylflavone (TMF) as markers. The results showed that glucose metabolism via oral glucose tolerance test was not affected by KP extract. Blood glucose levels of volunteers at 120 min after glucose loading were able to be returned to initial levels in placebo, KP 90 mg/day, and KP 180 mg/day groups both at baseline and 28-days of administration. The results of the pharmacokinetic study revealed that only TMF and PMF, but not 5,7-dimethoxyflavone (DMF) levels could be detected in human blood. The given doses of KP extract at 90 and 180 mg/day showed a linear dose-relationship of blood PMF concentration whereas blood TMF was detected only at high given dose (180 mg/day). The half-lives of PMF and TMF were 2–3 h. The maximum concentration (C(max)), area under the curve of blood concentration and time (AUC), and time to maximum concentration (T(max)) values of PMF and TMF estimated for the 180 mg/day dose were 71.2 ± 11.3, 63.0 ± 18.0 ng/mL; 291.9 ± 48.2, 412.2 ± 203.7 ng∙h/mL; and 4.02 ± 0.37, 6.03 ± 0.96 h, respectively. PMF was quickly eliminated with higher Ke and Cl than TMF at the dose of 180 mg/day of KP extract. In conclusion, the results demonstrated that KP extract had no effect on the glucose tolerance test. In addition, this is the first demonstration of the pharmacokinetic parameters of methoxyflavones of KP extract in healthy volunteers. The data suggest the safety of the KP extract and will be of benefit for further clinical trials using KP extract as food and sport supplements as well as a drug in health product development.
format Online
Article
Text
id pubmed-6566825
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65668252019-06-17 Glucose Tolerance Test and Pharmacokinetic Study of Kaempferia parviflora Extract in Healthy Subjects Sripanidkulchai, Bungorn Mekjaruskul, Catheleeya Areemit, Rosawan Cheawchanwattana, Areewan Sithithaworn, Jiraporn Nutrients Article Kaempferia parviflora Wall. ex Baker (KP), Krachaidam in Thai or Thai ginseng, is a herbal medicine that has many potential pharmacological effects. The effect of KP extract on blood glucose level in rodent was reported. This study focused on the oral glucose tolerance test and pharmacokinetic study in healthy volunteers administered with KP extract (90 and 180 mg/day, placebo). The oral glucose tolerance tests were performed at baselines and 28-days of administration. The pharmacokinetics were determined after a single dose administration of the tested products using 3,5,7,3′,4′-pentamethoxyflavone (PMF) and 5,7,4′-trimethoxylflavone (TMF) as markers. The results showed that glucose metabolism via oral glucose tolerance test was not affected by KP extract. Blood glucose levels of volunteers at 120 min after glucose loading were able to be returned to initial levels in placebo, KP 90 mg/day, and KP 180 mg/day groups both at baseline and 28-days of administration. The results of the pharmacokinetic study revealed that only TMF and PMF, but not 5,7-dimethoxyflavone (DMF) levels could be detected in human blood. The given doses of KP extract at 90 and 180 mg/day showed a linear dose-relationship of blood PMF concentration whereas blood TMF was detected only at high given dose (180 mg/day). The half-lives of PMF and TMF were 2–3 h. The maximum concentration (C(max)), area under the curve of blood concentration and time (AUC), and time to maximum concentration (T(max)) values of PMF and TMF estimated for the 180 mg/day dose were 71.2 ± 11.3, 63.0 ± 18.0 ng/mL; 291.9 ± 48.2, 412.2 ± 203.7 ng∙h/mL; and 4.02 ± 0.37, 6.03 ± 0.96 h, respectively. PMF was quickly eliminated with higher Ke and Cl than TMF at the dose of 180 mg/day of KP extract. In conclusion, the results demonstrated that KP extract had no effect on the glucose tolerance test. In addition, this is the first demonstration of the pharmacokinetic parameters of methoxyflavones of KP extract in healthy volunteers. The data suggest the safety of the KP extract and will be of benefit for further clinical trials using KP extract as food and sport supplements as well as a drug in health product development. MDPI 2019-05-25 /pmc/articles/PMC6566825/ /pubmed/31130666 http://dx.doi.org/10.3390/nu11051176 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sripanidkulchai, Bungorn
Mekjaruskul, Catheleeya
Areemit, Rosawan
Cheawchanwattana, Areewan
Sithithaworn, Jiraporn
Glucose Tolerance Test and Pharmacokinetic Study of Kaempferia parviflora Extract in Healthy Subjects
title Glucose Tolerance Test and Pharmacokinetic Study of Kaempferia parviflora Extract in Healthy Subjects
title_full Glucose Tolerance Test and Pharmacokinetic Study of Kaempferia parviflora Extract in Healthy Subjects
title_fullStr Glucose Tolerance Test and Pharmacokinetic Study of Kaempferia parviflora Extract in Healthy Subjects
title_full_unstemmed Glucose Tolerance Test and Pharmacokinetic Study of Kaempferia parviflora Extract in Healthy Subjects
title_short Glucose Tolerance Test and Pharmacokinetic Study of Kaempferia parviflora Extract in Healthy Subjects
title_sort glucose tolerance test and pharmacokinetic study of kaempferia parviflora extract in healthy subjects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566825/
https://www.ncbi.nlm.nih.gov/pubmed/31130666
http://dx.doi.org/10.3390/nu11051176
work_keys_str_mv AT sripanidkulchaibungorn glucosetolerancetestandpharmacokineticstudyofkaempferiaparvifloraextractinhealthysubjects
AT mekjaruskulcatheleeya glucosetolerancetestandpharmacokineticstudyofkaempferiaparvifloraextractinhealthysubjects
AT areemitrosawan glucosetolerancetestandpharmacokineticstudyofkaempferiaparvifloraextractinhealthysubjects
AT cheawchanwattanaareewan glucosetolerancetestandpharmacokineticstudyofkaempferiaparvifloraextractinhealthysubjects
AT sithithawornjiraporn glucosetolerancetestandpharmacokineticstudyofkaempferiaparvifloraextractinhealthysubjects